Clinical Trial Update: Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study of LY573636-sodium in Acute Myeloid Leukemia and Essential Thrombocythemia completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Essential Thrombocythemia

Drugs mentioned

• LY573636-sodium

Snippet

Sponsor: Eli Lilly and Company | Conditions: Acute Myeloid Leukemia, Essential Thrombocythemia | Phase 1 | Status: COMPLETED | Results posted: 2018-10-16